Study for adverse reactions monitoring of cefazolin sodium pentahydrate for injection

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023508

Enrollment

Unknown

Registered

2019-05-31

Start date

2018-03-01

Completion date

Unknown

Last updated

2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who take at least 1 time of cefazolin sodium pentahydrate for injection in the inpatient department of the research institutes.

Exclusion criteria

Exclusion criteria: If the adverse reactions / events of a case maybe caused by other reasons,the experts groups need to discuss exclude the case or not.

Design outcomes

Primary

Measure	Time frame
Adverse reaction;	—

Countries

China

Contacts

Public ContactJin Li

Lijin@gdyl.org+86 13824492310

Outcome results